M. Lewin
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
- Surgery 27
- Pediatric Hepatobiliary Diseases and Treatments 5
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Co-authors
- Ralph Weissleder (2 shared papers)David T Scadden (1 shared paper)Nadia Carlesso (1 shared paper)Xiaowu Tang (1 shared paper)David G. Cory (1 shared paper)Ching‐Hsuan Tung (1 shared paper)Jean‐Michel Tubiana (21 shared papers)Lionel Arrivé (21 shared papers)
- Journals
- European Radiology (7 papers)Radiology (5 papers)American Journal of Roentgenology (5 papers)Radiographics (3 papers)Hepatology (3 papers)
- Partner nations
- FranceUnited StatesJapan
In The Last Decade
M. Lewin
76 papers receiving 3.4k citations
M. Lewin's Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 514
- Biomaterials 541
- Radiology, Nuclear Medicine and Imaging 486
- Surgery 748
- Biomedical Engineering 570
Countries citing papers authored by M. Lewin
This map shows the geographic impact of M. Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lewin more than expected).
Fields of papers citing papers by M. Lewin
This network shows the impact of papers produced by M. Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lewin. The network helps show where M. Lewin may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lewin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Hit paper breakdown → | 2000 | 1411 |
| 2 | 2007 | 217 | |
| 3 | 1999 | 125 | |
| 4 | 2010 | 121 | |
| 5 | 2000 | 90 | |
| 6 | 2006 | 77 | |
| 7 | 2006 | 75 | |
| 8 | 2005 | 70 | |
| 9 | 2006 | 70 | |
| 10 | 2020 | 65 | |
| 11 | 2009 | 57 | |
| 12 | 2004 | 55 | |
| 13 | 2019 | 55 | |
| 14 | 2006 | 53 | |
| 15 | 2020 | 51 | |
| 16 | 2008 | 49 | |
| 17 | 2007 | 49 | |
| 18 | 2017 | 40 | |
| 19 | Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes. | 2000 | 39 |
| 20 | 2015 | 37 |
About M. Lewin
M. Lewin is a scholar working on Surgery, Hepatology, Pulmonary and Respiratory Medicine, Genetics and Oncology, having authored 83 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Genetic and Kidney Cyst Diseases (8 papers), Liver Disease Diagnosis and Treatment (8 papers), MRI in cancer diagnosis (5 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Biliary and Gastrointestinal Fistulas (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). The work is most often cited by research in Hepatology (514 citations), Biomaterials (541 citations), Radiology, Nuclear Medicine and Imaging (486 citations), Surgery (748 citations) and Biomedical Engineering (570 citations). M. Lewin has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Ralph Weissleder, David T Scadden, Nadia Carlesso, Xiaowu Tang, David G. Cory, Ching‐Hsuan Tung, Jean‐Michel Tubiana, Lionel Arrivé, Christine Hoeffel and Jean–François Fléjou. Their work appears in journals such as European Radiology, Radiology, American Journal of Roentgenology, Radiographics and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.